arrow
M

Mark E. Snyder

university of pittsburgh medical center
H指数:31
被引数:6,687

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Authors’ reply

作者回复

2026-02-250
PRE
Immune gene correlation networks differentiate both chronic lung allograft dysfunction and survival

免疫基因相关性网络可区分慢性肺移植功能障碍与生存

2026-02-100
OA
ISHLT Consensus Statement on Short Telomere Syndrome and Lung Transplantation

国际心肺移植学会(ISHLT)关于短端粒综合征与肺移植的共识声明

2026-01-080
PRE
Lung Epithelium Releases Growth Differentiation Factor 15 in Response to Pathogen-mediated Injury

肺上皮释放生长分化因子15响应病原体介导的损伤

2024-05-012
OAAI
Cross-Regulation of F-Box Protein FBXL2 with T-bet and TNF-α during Acute and Chronic Lung Allograft Rejection
2022-11-014
OA
CD4+ T-Cell Dysfunction in Severe COVID-19 Disease Is Tumor Necrosis Factor-α/Tumor Necrosis Factor Receptor 1-Dependent
2022-06-1527
OAAI
Immune and epithelial determinants of age-related risk and alveolar injury in fatal COVID-19

致死性新型冠状病毒肺炎中年龄相关风险和肺泡损伤的免疫和上皮决定因素

2022-06-085
OA
Modulation of tissue resident memory T cells by glucocorticoids after acute cellular rejection in lung transplantation

肺移植急性细胞排斥反应后糖皮质激素对组织驻留记忆T细胞的调节

2022-03-1421
OAAI
Geographic disparities in lung transplantation in the United States before and after the November 2017 allocation change

2017年11月分配变化前后美国肺移植的地理差异

2022-03-015
OAAI
Rate of recipient-derived alveolar macrophage development and major histocompatibility complex cross-decoration after lung transplantation in humans
2022-02-017
OAAI
Type-1 immunity and endogenous immune regulators predominate in the airway transcriptome during chronic lung allograft dysfunction

慢性同种异体肺功能障碍期间,1型免疫和内源性免疫调节剂在气道转录组中占主导地位

2021-06-0124
OAAI